This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Cedars-Sinai Medical Center. Active years: 2022-2024.
Company Filing History:
Years Active: 2022-2024
Title: Romain Gallet: Innovator in Cardiac Treatment
Introduction
Romain Gallet is a prominent inventor based in Paris, France. He has made significant contributions to the field of cardiac treatment, particularly in addressing heart failure with preserved ejection fraction (HFpEF). His innovative work has led to the development of new therapeutic approaches that show promise in improving patient outcomes.
Latest Patents
Romain Gallet holds 2 patents related to his groundbreaking research. His latest patents focus on the use of cardiosphere-derived cells (CDCs) and their exosomes in the treatment of HFpEF. This condition is characterized by heart failure symptoms despite normal left ventricular ejection fraction. The patents describe compositions and methods that utilize CDCs to enhance left ventricular structure and function. Administration of these cells has been shown to improve left ventricular relaxation, reduce end-diastolic pressure, and decrease lung congestion, ultimately leading to enhanced survival rates. Additionally, the administration of CDC-derived exosomes has demonstrated improvements in diastolic dysfunction and reduced mortality rates in patients with HFpEF.
Career Highlights
Romain Gallet is affiliated with Cedars-Sinai Medical Center, where he conducts his research and development work. His innovative contributions have positioned him as a key figure in the advancement of cardiac therapies. His research is pivotal in exploring new avenues for treating heart failure, particularly in patients who do not respond to standard therapies.
Collaborations
Romain Gallet collaborates with esteemed colleagues in the field, including Eduardo Marban. Their joint efforts aim to further the understanding and treatment of cardiac conditions, enhancing the potential for successful patient outcomes.
Conclusion
Romain Gallet's work in the field of cardiac treatment exemplifies the impact of innovation on healthcare. His patents and research are paving the way for new therapeutic strategies that could significantly improve the lives of patients suffering from heart failure.